Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
- 1 August 2004
- journal article
- clinical trial
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 30 (6), 643-649
- https://doi.org/10.1016/j.ejso.2004.04.013
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Value of palliative resection in gastric cancerBritish Journal of Surgery, 2002
- Cancer Incidence and Incidence Rates in Japan in 1997: Estimates Based on Data from 12 Population-based Cancer RegistriesJapanese Journal of Clinical Oncology, 2002
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- Adjuvant Chemoradiotherapy for Gastric CancerNew England Journal of Medicine, 2002
- A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric CancerAnnals of Surgical Oncology, 2001
- Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trialEuropean Journal Of Cancer, 1999
- Extended Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal CancerNew England Journal of Medicine, 1998
- 1180: First demonstration of anti-lymphoma activity of BCL-2 antisense molecule-G3139; Results of phase I/IIA clinical trialEuropean Journal Of Cancer, 1997
- A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancerAnti-Cancer Drugs, 1997